A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection
Urothelial carcinoma of the urinary bladder (UCB) or bladder cancer remains a major health problem with high morbidity and mortality rates, especially in the western world. UCB is also associated with the highest cost per patient. In recent years numerous markers have been evaluated for suitability...
Main Authors: | Ayssar A. Elamin, Saskia Klunkelfuß, Susanne Kämpfer, Wulf Oehlmann, Matthias Stehr, Christopher Smith, Guy R. Simpson, Richard Morgan, Hardev Pandha, Mahavir Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01484/full |
Similar Items
-
Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response
by: Nicola E. Annels, et al.
Published: (2020-02-01) -
Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
by: Yuri M. Shlyapnikov, et al.
Published: (2021-02-01) -
Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival
by: Watt J, et al.
Published: (2020-04-01) -
Gene Expression Profiling of Chemically Induced Rat Bladder Tumors
by: Ruisheng Yao, et al.
Published: (2007-03-01) -
Lipid Droplets and Mycobacterium leprae Infection
by: Ayssar A. Elamin, et al.
Published: (2012-01-01)